The identification of high-performing antibodies for Sequestosome-1 for use in Western blot, immunoprecipitation and immunofluorescence
F1000Research · 10.07.2024 · 12 · 324
DOI: 10.12688/f1000research.132628.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, online erschienen am 10.07.2024. Verfasst von Riham Ayoubi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H…. Hauptthemen laut MEDLINE: Sequestosome-1 Protein, Fluorescent Antibody Technique, Immunoprecipitation, Blotting, Western. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mitacs, ALS Association, Genome Canada.
Abstract (Originalsprache)
Sequestosome-1, encoded by the gene SQSTM1 , functions as a bridge between ubiquitinated proteins and the proteasome or autophagosome, thereby regulating protein degradation pathways. Loss of Sequestosome-1 is hypothesized to enhance neurodegeneration progression in several diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal disorders (FTD). Sequestosome-1 reproducible research would be facilitated with the availability of well-characterized anti-Sequestosome-1 antibodies. In this study, we characterized seventeen Sequestosome-1 commercial antibodies for Western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many high-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.
- The Neuro's Early Drug Discovery Unit (EDDU), Structural Genomics Consortium, McGill University, Montreal, Québec, H3A 2B4, Canada.
ORCID-Profile: Kathleen Southern, Carl Laflamme
Förderung
- Mitacs
- ALS Association
- Genome Canada
- ALS Society of Canada
- Genome Quebec
- Canadian Institutes of Health Research Foundation
- Motor Neurone Disease Association
- Ontario Genomics
Zitieren
APA
Ayoubi, R., Alshafie, W., Shlaifer, I., Southern, K., McPherson, P. S., Laflamme, C., & NeuroSGC/YCharOS/EDDU collaborative group (2024). The identification of high-performing antibodies for Sequestosome-1 for use in Western blot, immunoprecipitation and immunofluorescence. F1000Research, 12, 324. https://doi.org/10.12688/f1000research.132628.2
Vancouver
Ayoubi R, Alshafie W, Shlaifer I, Southern K, McPherson PS, Laflamme C, et al. The identification of high-performing antibodies for Sequestosome-1 for use in Western blot, immunoprecipitation and immunofluorescence. F1000Research. 2024;12:324. doi:10.12688/f1000research.132628.2
BibTeX
@article{Ayoubi2024,
author = {Ayoubi, Riham and Alshafie, Walaa and Shlaifer, Irina and Southern, Kathleen and McPherson, Peter S and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group},
title = {The identification of high-performing antibodies for Sequestosome-1 for use in Western blot, immunoprecipitation and immunofluorescence},
journal = {F1000Research},
year = {2024},
volume = {12},
pages = {324},
doi = {10.12688/f1000research.132628.2}
}
EUVIMED